Connecting you to content on EBSCOhost

Works matching IS 11782595 AND DT 2017 AND VI 31 AND IP 5

Results: 7

1

Preferences for Receiving Results from a Rare Disease Clinical Trial: A Survey of Subjects with Friedreich's Ataxia and their Parents.

Published in:

Pharmaceutical Medicine, 2017, v. 31, n. 5, p. 329, doi. 10.1007/s40290-017-0201-y

By:

Amelot, Vincent;
Bungener, Catherine;
Guilmin-Crepon, Sophie;
Schroedt, Julien;
Alberti, Corinne;
Husson, Isabelle

Publication type:

Article

2

First Amendment Protection of Evidence-Based Promotion of Prescription Drugs: A Study of Published Clinical Evidence Supporting Off-Label Promotion in the USA.

Published in:

Pharmaceutical Medicine, 2017, v. 31, n. 5, p. 309, doi. 10.1007/s40290-017-0202-x

By:

Herbst, Jennifer;
Richards, Victoria;
Schramm, Mary;
Mattie, Angela

Publication type:

Article

3

Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey.

Published in:

Pharmaceutical Medicine, 2017, v. 31, n. 5, p. 339, doi. 10.1007/s40290-017-0203-9

By:

Davis, Kimberly;
Asiimwe, Alex;
Zografos, Laurie;
McSorley, David;
Andrews, Elizabeth

Publication type:

Article

4

Forum.

Published in:: Pharmaceutical Medicine, 2017, v. 31, n. 5, p. 353, doi. 10.1007/s40290-017-0204-8
Publication type:: Article

5

Novel Early Phase Clinical Trial Design in Oncology.

Published in:

Pharmaceutical Medicine, 2017, v. 31, n. 5, p. 297, doi. 10.1007/s40290-017-0205-7

By:

O'Brien, Ciara;
Carter, Louise;
Cook, Natalie;
Dean, Emma

Publication type:

Article

6

Major Pharmaceutical Conferences and Courses.

Published in:: Pharmaceutical Medicine, 2017, v. 31, n. 5, p. 371, doi. 10.1007/s40290-017-0206-6
Publication type:: Article

7

Analysis of Safety-Related Regulatory Actions for New Drugs in Japan by Nature of Identified Risks.

Published in:

Pharmaceutical Medicine, 2017, v. 31, n. 5, p. 317, doi. 10.1007/s40290-017-0198-2

By:

Fujikawa, Makoto;
Ono, Shunsuke

Publication type:

Article